TC
INSY

TFS Capital’s Insys Therapeutics, Inc. INSY Stock Holding History

TFS Capital’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-38,098
Closed -$1.08M – 1017
2015
Q3 		$1.08M Buy
+38,098
New +$1.4M 0.1% 317
2014
Q2 		– Sell
-35,302
Closed -$731K – 1470
2014
Q1 		$731K Sell
35,302
-105,311
-75% -$2.09M 0.05% 581
2013
Q4 		$1.81M Sell
140,613
-63,552
-31% -$881K 0.09% 343
2013
Q3 		$2.38M Buy
+204,165
New +$1.68M 0.11% 276

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

TFS Capital's INSY Position: Q4 2015 in Review

TFS Capital sold out of Insys Therapeutics, Inc. (INSY) in Q4 2015, closing a stake of 38,098 shares — an estimated $1.08M sold.

TFS Capital first reported a position in INSY in Q3 2013 and held it in 4 quarters. The position peaked at $2.38M in Q3 2013. 154 funds tracked by Wall St. Rank hold INSY as of Q4 2015.

  • TFS Capital reported no remaining Insys Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • TFS Capital sold 38,098 Insys Therapeutics, Inc. shares in Q4 2015, an estimated $1.08M.
  • TFS Capital first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 4 quarters.
  • TFS Capital's Insys Therapeutics, Inc. position peaked at $2.38M in Q3 2013.
  • 154 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2015.

Based on TFS Capital's 13F filing for Q4 2015, filed 29 Jan 2016.